• Users Online: 559
  • Print this page
  • Email this page


 
 
Table of Contents
LETTER TO THE EDITOR
Year : 2020  |  Volume : 31  |  Issue : 1  |  Page : 42

Adiponectin and proto-oncogene MYC in prostate cancer: How far are we with the evidence?


Nishtha Surgical Hospital and Research Centre, Patan, Gujarat, India

Date of Submission25-Oct-2019
Date of Decision28-Oct-2019
Date of Acceptance12-Nov-2019
Date of Web Publication20-Feb-2020

Correspondence Address:
Dr. Vipul D Yagnik
77, Siddhraj Nagar, Rajmahal Road, Patan - 384 265, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/UROS.UROS_83_19

Get Permissions


How to cite this article:
Yagnik VD. Adiponectin and proto-oncogene MYC in prostate cancer: How far are we with the evidence?. Urol Sci 2020;31:42

How to cite this URL:
Yagnik VD. Adiponectin and proto-oncogene MYC in prostate cancer: How far are we with the evidence?. Urol Sci [serial online] 2020 [cited 2020 Apr 8];31:42. Available from: http://www.e-urol-sci.com/text.asp?2020/31/1/42/278878



Dear Editor,

I read with great interest an article entitled “Adiponectin and Proto-Oncogene MYC in prostate cancer (PCa): How Far Are We with the Evidence?” by Hakim[1] in the recent issue of the esteemed journal. It is an interesting article, and the author had described the controversy associated with adiponectin and proto-oncogene MYC in PCa. I have an observation related to this article, which you may find useful.

The author had mentioned that, according to the GLOBOCAN data 2018, PCa is the most common malignancy among males and represents the 5th leading cause of death from cancer in men.[1] I would like to state that, after careful observation of the GLOBOCON statistics data 2018, I find that lung cancer is the most common cancer (11.6% of the total cases), closely followed by PCa (7.1%) in male and breast cancer in female.[2]



 
  References Top

1.
Hakim L. Adiponectin and proto-oncogene MYC in prostate cancer: How far are we with the evidence? Urol Sci 2019;30:197-8.  Back to cited text no. 1
  [Full text]  
2.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.  Back to cited text no. 2
    




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed106    
    Printed2    
    Emailed0    
    PDF Downloaded16    
    Comments [Add]    

Recommend this journal